Schedule 13G ownership disclosure

PRECISION BIOSCIENCES INC

Security class unavailable · CUSIP: 74019P108

Event date: 2022-06-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,407,440
Percent of class
16.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-074786
Form type
SC 13G
Filer
NOVARTIS PHARMA AG
CIK
CIK 1030617
Filed
Jun 27, 2022
Reporting period
Jun 15, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub